![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CoreValve Initiates European Trial Using Its ReValving System
CoreValve Initiates European Trial Using Its ReValving System
CoreValve announced that its proprietary percutaneous ReValving system, which features a pericardium aortic heart valve mounted in a self-expanding frame, has been implanted successfully for the first time in Europe in the cardiac catheterization laboratory at the Heart Center, Siegburg, Germany. As a result, the 73-year-old female patient was able to avoid open-heart surgery to treat her aortic calcified stenosis.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct